By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


SEARCH JOBS

Teva Pharmaceutical Industries Ltd. develops, produces and markets ethical drugs, generic drugs, and fine chemicals for the pharmaceutical industry and disposable products for hospitals and home care services.


YEAR FOUNDED:

1901

LEADERSHIP:

Founders: Chaim Salomon, Moshe Levin, and Yitschak Elstein

CEO: Erez Vigodman

CEO Global Operations: Carlo de Notaristefani

CEO Global Specialty Medicines: Rob Koremans

CEO Global Generic Medicines: Sigudur (Siggi) Olafsson

CFO: Eyal Desheh

CMO (Medical):

CSO (Scientific): Michael Hayden

JOBS:

Please click here for Teva Pharma job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


PRODUCTS:

All Products


Key Statistics


Email:
Ownership: Public

Web Site: Teva
Employees: 5,700
Symbol: TEVA
 



Industry
Biotechnology






Company News
AstraZeneca PLC (AZN) CEO Breaks Silence on Teva (TEVA) Rumors, Urges Staff to Remain Focused in Leaked Memo 7/21/2017 5:37:40 AM
Teva (TEVA) Release: NICE Recommends CINQAERO (Reslizumab) For The Treatment Of Severe Eosinophilic Asthma 7/20/2017 11:01:11 AM
European Commission (EC) Accuses Teva (TEVA), Cephalon (CEPH) of Anti-Competitive Behavior 7/17/2017 6:04:08 AM
Teva (TEVA) Enhances Board Of Directors As All Proposals Approved At Annual General Meeting Of Shareholders 7/13/2017 11:12:37 AM
Rumor Alert: AstraZeneca PLC (AZN) CEO to Become Teva (TEVA)'s New Leader 7/12/2017 4:41:50 PM
Teva (TEVA) Accuses Former Top Exec of Passing on Trade Secrets to Boyfriend—CEO of Rival Apotex 7/12/2017 6:35:02 AM
Teva (TEVA) And The Huntington Study Group Announce Publication Of Data For AUSTEDO (Deutetrabenazine) Tablets In Huntington Disease From ARC-HD Study In JAMA Neurology 7/11/2017 9:07:35 AM
Teva (TEVA) To Report Second Quarter 2017 Financial Results On August 3, 2017 7/11/2017 9:01:25 AM
Teva (TEVA) Announces Publication Of AIM-TD Study Results In The Lancet Psychiatry For The Investigational Use Of Deutetrabenazine In Tardive Dyskinesia 6/29/2017 9:56:12 AM
Celltrion And Teva (TEVA) Announce U.S. FDA Acceptance Of Biologics License Application For Proposed Biosimilar To Rituxan (Rituximab) 6/29/2017 9:33:11 AM
12345678910...
//-->